Melatonin inhibits amphetamine-induced nitric oxide synthase mRNA overexpression in microglial cell lines

Neuroscience Letters

Volumn 439, Issue 2, 2008, Pages 134-137

  Tocharus, Jiraporn ^a   Chongthammakun, Sukumal ^b   Govitrapong, Piyarat ^b,c  

^a NARESUAN UNIVERSITY   (Thailand)

^b Mahidol University ^*  (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Amphetamine; Immune; Inflammatory; Melatonin; Microglial; Nitric oxide synthase; Parkinson's disease

Indexed keywords

AMPHETAMINE; MELATONIN; NITRIC OXIDE SYNTHASE; S METHYLPSEUDOTHIOUREA; THIOUREA DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GENE OVEREXPRESSION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; CELL LINE, TRANSFORMED; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; ISOTHIURONIUM; LIPOPOLYSACCHARIDES; MELATONIN; MICROGLIA; NITRIC OXIDE SYNTHASE; RATS; RNA, MESSENGER;

EID: 44649122048     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.036     Document Type: Article

References (32)

1. Ali S.F., and Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann. N. Y. Acad. Sci. 844 (1998) 122-130
2. Bal-Price A., and Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitoxicity. J. Neurosci. 21 (2001) 6480-6491
3. Bashkatova V., Kraus M.M., Vanin A., Hornick A., and Prast H. Comparative effects of NO-synthase inhibitor and NMDA antagonist on generation of nitric oxide and release of amino acids and acetylcholine in the rat brain elicited by amphetamine neurotoxicity. Ann. N. Y. Acad. Sci. 1025 (2004) 221-230
4. Bashkatova V., Kraus M.M., Hornick A., Philippi A., and Prast H. 7-nitroindazole, nNOS inhibitor, attenuates amphetamine-induced amino acid release and nitric oxide generation but not lipid peroxidation in the rat brain. J. Neural. Transm. 112 (2005) 779-788
5. Bettahi I., Pozo D., Osuna C., Reiter R.J., Acuna-Castroviejo D., and Guerrero J.M. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20 (1996) 205-210
6. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17 (2003) 1775-1788
7. Carrillo-Vico A., Lardone P.J., Naji L., Fernandez-Santos J.M., Martin-Lacave I., Guerrero J.M., and Calvo J.R. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J. Pineal Res. 39 (2005) 400-408
8. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., and Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149 (1992) 2736-2741
9. Frey B.N., Valvassori S.S., Gomes K.M., Martins M.R., Dal-Pizzol F., Kaczynski F., and Quevedo J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 1097 (2006) 224-229
10. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., and Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFκB activation. FASEB J. 12 (1998) 685-693
11. Klongpanichapak S., Phansuwan-Pujito P., Ebadi M., and Govitrapong P. Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity. J. Pineal Res. 43 (2007) 65-73
12. Knowles R.G., and Moncada S. Nitric oxide synthase in mammals. Biochem. J. 298 (1994) 249-258
13. Lee S.C., Zhao M.L., Hirano A., and Dickson D.W. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirono bodies, neurofibrillary tangles, and senile plaques. J. Neuropathol. Exp. Neurol. 58 (1999) 1163-1169
14. Leon J., Vives F., Camacho E., Espinosa A., Gallo M.A., and Acuna-Castroviejo D. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J. Neuroendocrinol. 10 (1998) 297-302
15. Levi M.S., and Brimble M.A. A review of neuroprotective agents. Curr. Med. Chem. 11 (2004) 2383-2397
16. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304 (2003) 1-7
17. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., and Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151 (1993) 2132-2141
18. Moro M.A., Cardenas A., Hurtado O., Leza J.C., and Lizasoain I. Role of nitric oxide after brain ischemia. Cell Calcium 36 (2004) 265-275
19. O'Callaghan J.P., and Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270 (1994) 741-751
20. Pozo D., Reiter R.J., Calvo J.R., and Guerrero J.M. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell Biochem. 65 (1997) 430-442
21. Reiter R.J., Tan D.X., Osuna C., and Gitto E. Actions of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 7 (2000) 448-458
22. Rodriguez S., Leal C., Portilla E., Olivares N., and Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide. J. Surg. Res. 100 (2001) 141-149
23. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., and Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 36 (2004) 1-9
24. Santamaria A., Flores-Escartin A., Martinez J.C., Osorio L., Galvan-Arzate S., Pedraza-Chaverri J., Maldonado P.D., Medina-Campos O.N., Jimenez-Capdeville M.E., Manjarrez J., and Rios C. Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic. Biol. Med. 15 (2003) 418-427
25. Serin M., Gulbas H., Gurses I., Erkal H.S., and Yucel N. The histopathological evaluation of the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy in a rat model. Int. J. Radiat. Biol. 83 (2007) 187-193
26. Sewerynek E., Melchiorri D., Chen L., and Reiter R.J. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Rad. Biol. Med. 19 (1995) 909-1909
27. Singh S., Das T., Ravindran A., Chaturvedi R.K., Shukla Y., Agarwal A.K., and Dikshit M. Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease. Redox Rep. 10 (2005) 103-109
28. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Limson J., Weintraub S.T., and Qi W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29 (2000) 1177-1185
29. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 42 (2007) 28-42
30. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., and Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311 (2004) 1-7
31. Tomaz-Zapico C., and Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 39 (2005) 99-104
32. Wan F.J., Tung C.S., Shiah I.S., and Lin H.C. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine. Eur. Neuropsychopharmacol. 16 (2006) 147-153